skip to primary navigationskip to content
 

CEGX: The spinout that’s measuring the epigenome to improve human health

Cambridge Enterprise will be holding a series of departmental Roadshow events showcasing some of the most prominent research that has spun out of the university.
When Sep 12, 2017
from 06:00 PM to 08:00 PM
Where Pfizer Lecture Theatre, Department of Chemistry, Lensfield Road
Add event to calendar vCal
iCal

These events will provide a networking opportunity to meet like-minded people with an interest in entrepreneurship and is open to academics, postdocs and PhDs alike from across all departments at the University.

On 12 September, hear Dr Jason Mellad, Chief Executive Officer (CEO) at Cambridge Epigenetix, give a talk about the company’s route to commercialisation and how the relationship with Cambridge Enterprise was able to support this journey.

Cambridge Epigenetix, a pioneer in the development of epigenetic sequencing, was founded in 2012 by Prof Shankar Balasubramanian of the Department of Chemistry.

The company is focused on developing best-in-class tools to make studying DNA methylation and DNA hydroxymethylation as easy as studying DNA sequencing.

Further information and details on how to register can be found here.

OPdA Tweets

RSS Feed Latest news

Free places for postdocs at the Genomics! Venture Creation Weekend

Oct 16, 2018

15 free places at the Genomics! Venture Creation Weekend (16-18 November, at Cambridge Judge Business School) are available to Cambridge postdocs through the OPdA and p2i network.

Staff Counselling Service Wellbeing Group for Postdocs - starts 12 October

Sep 24, 2018

The Staff Counselling Service would like to offer you an opportunity to join their Wellbeing Group for Postdocs.

Language courses now available at the Biomedical Campus

Sep 21, 2018

This year the University of Cambridge Language Centre will be running lunchtime language courses at the Postdoc Centre @ Biomedical Campus.

View all news